21st Century Pharmacovigilance: Intuition, Science, and the Role of Artificial Intelligence

Abstract

In an environment of real world evidence, patient reported outcomes, expanding expedited and conditional review pathways for the treatment not only for cancers, but for a broad spectrum of serious and life-threatening diseases, we must care more than ever about pharmacovigilance via more regular and creative risk management plans to be sure, but also through a more diligent effort to understand just what “safety and surveillance” is about in the 21^st century. At least part of the solution lies with something called “Artificial Intelligence.”